MYLI
ALXN

Meiji Yasuda Life Insurance’s Alexion Pharmaceuticals ALXN Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,912
Closed -$327K – 325
2020
Q2 		$327K Hold
2,912
– – 0.01% 252
2020
Q1 		$261K Buy
2,912
+227
+8% +$22.3K 0.05% 237
2019
Q4 		$290K Hold
2,685
– – 0.04% 279
2019
Q3 		$263K Sell
2,685
-314
-10% -$35.4K 0.04% 286
2019
Q2 		$393K Sell
2,999
-5,066
-63% -$653K 0.06% 259
2019
Q1 		$1.09M Sell
8,065
-455
-5% -$56.6K 0.16% 152
2018
Q4 		$830K Buy
8,520
+4,220
+98% +$499K 0.13% 177
2018
Q3 		$598K Hold
4,300
– – 0.07% 232
2018
Q2 		$534K Sell
4,300
-1,690
-28% -$198K 0.07% 230
2018
Q1 		$668K Sell
5,990
-310
-5% -$37.1K 0.1% 197
2017
Q4 		$753K Buy
6,300
+2,000
+47% +$244K 0.1% 191
2017
Q3 		$603K Buy
+4,300
New +$584K 0.09% 197
2016
Q4 		– Sell
-4,597
Closed -$563K – 364
2016
Q3 		$563K Hold
4,597
– – 0.08% 228
2016
Q2 		$537K Hold
4,597
– – 0.09% 193
2016
Q1 		$640K Hold
4,597
– – 0.1% 185
2015
Q4 		$877K Sell
4,597
-260
-5% -$45.4K 0.14% 161
2015
Q3 		$760K Sell
4,857
-1,430
-23% -$261K 0.13% 171
2015
Q2 		$1.14M Sell
6,287
-700
-10% -$121K 0.18% 152
2015
Q1 		$1.21M Sell
6,987
-1,488
-18% -$269K 0.19% 153
2014
Q4 		$1.57M Buy
8,475
+90
+1% +$16.7K 0.23% 108
2014
Q3 		$1.39M Buy
8,385
+1,743
+26% +$286K 0.21% 113
2014
Q2 		$1.04M Sell
6,642
-600
-8% -$94.7K 0.16% 142
2014
Q1 		$1.1M Sell
7,242
-823
-10% -$131K 0.19% 132
2013
Q4 		$1.07M Hold
8,065
– – 0.18% 132
2013
Q3 		$937K Sell
8,065
-785
-9% -$86.1K 0.17% 146
2013
Q2 		$816K Buy
+8,850
New +$853K 0.15% 157

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meiji Yasuda Life Insurance's ALXN Position: Q3 2020 in Review

Meiji Yasuda Life Insurance sold out of Alexion Pharmaceuticals (ALXN) in Q3 2020, closing a stake of 2,912 shares — an estimated $327K sold.

Meiji Yasuda Life Insurance first reported a position in ALXN in Q2 2013 and held it in 26 quarters. The position peaked at $1.57M in Q4 2014. 708 funds tracked by Wall St. Rank hold ALXN as of Q3 2020.

  • Meiji Yasuda Life Insurance reported no remaining Alexion Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Meiji Yasuda Life Insurance sold 2,912 Alexion Pharmaceuticals shares in Q3 2020, an estimated $327K.
  • Meiji Yasuda Life Insurance first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • Meiji Yasuda Life Insurance's Alexion Pharmaceuticals position peaked at $1.57M in Q4 2014.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2020.

Based on Meiji Yasuda Life Insurance's 13F filing for Q3 2020, filed 12 Nov 2020.